Odyssey Therapeutics, Inc.
Statements
Cash Flow
Odyssey Therapeutics, Inc. (ODTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -35 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| -34 | -39 | -34 | -41 | -35 | |
| 1.3 | 1.3 | 1.3 | 1.2 | 1.0 | |
| 2.7 | 3.0 | 3.7 | 2.6 | 5.7 | |
| -2.5 | -5.3 | 2.4 | -7.2 | 1.2 | |
| 0.3 | 0.9 | 0.0 | 0.1 | 0.2 | |
| – | – | – | 35 | -211 | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | |
| 6.8 | 0.2 | 119 | 0.5 | 292 | |
| 20 | -4.2 | 108 | -5.7 | 46 | |
| -35 | -40 | -34 | -41 | -35 |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.